
Pfizer Inc. said Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster shot for Americans 65 and older. In a statement announcing its request, Pfizer relied on data from two studies out of Israel that have been published without peer review on pre-print servers.… read on > read on >